Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer

[1]  C. Simopoulos,et al.  Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  A. Harris,et al.  ‘Invading edge vs. inner’ (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non‐small cell lung cancer , 2000, The Journal of pathology.

[3]  A. Giatromanolaki,et al.  Cancer vascularization: implications in radiotherapy? , 2000, International journal of radiation oncology, biology, physics.

[4]  S. Fox,et al.  Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39 , 2000, British Journal of Cancer.

[5]  A. Giatromanolaki,et al.  Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression. , 1999, Cancer research.

[6]  V. Dixit,et al.  Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[7]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[8]  Athens Greece,et al.  Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. , 1997, Experimental cell research.

[10]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[11]  S. Fox,et al.  Thymidine phosphorylase is angiogenic and promotes tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R Bicknell,et al.  Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. , 1993, Cancer research.

[13]  Sandra R. Smith,et al.  Growth factor effects on cells of the vascular wall: a survey. , 1993, Growth factors.

[14]  A. Harris,et al.  Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. , 1992, Seminars in cancer biology.

[15]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[16]  D. Mason,et al.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.

[17]  K. Hori,et al.  In vivo Analysis of Tumor Vascularization in the Rat , 1990, Japanese journal of cancer research : Gann.

[18]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[19]  W. Thompson,et al.  Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth , 1987, The Journal of pathology.